Novartis in the news

China sees global turmoil as opportunity to be 'business friendly', says Novartis chief

Read on: Financial Times

Novartis to buy Regulus Therapeutics for as much as $1.7 billion

Read on: LA Times

Novartis posts better-than-expected sales driven by medicine demand

Read on: Euronews

Novartis posts better-than-expected first-quarter sales, raises full-year guidance

Read on: CNBC News

Swiss drugmaker Novartis to invest $23bn in US manufacturing and RD

Read on: Financial Times

Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

Read on: CNBC News

Novartis sees radioactive cancer drugs becoming $10bn business: CEO

Read on: Nikkei

Novartis agrees $3bn deal to buy heart drug biotech from Blackstone

Read on: Financial Times

Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales

Read on: CNBC News

Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio

Read on: The Wall Street Journal

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

Read on: CNBC News

Siemens Healthineers boosts cancer imaging with EUR200mn Novartis deal

Read on: Financial Times

Novartis warns prostate cancer drug price will remain high

Read on: Financial Times

Novartis Raises Guidance as Key Drugs Boost Sales

Read on: The Wall Street Journal

Novartis Raises Guidance as Key Drugs Boost Sales

Read on: The Wall Street Journal

Stocks making the biggest premarket moves: General Motors, GE Aerospace, Novartis, JetBlue and more

Read on: CNBC News

Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs

Read on: CNBC News

Novartis CEO: Broadly Positive About Business Momentum

Read on: Bloomberg

Novartis Ups Guidance on Profit, Sales Growth

Read on: The Wall Street Journal